Sector revisions Caplin Point Laboratories Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 07:05:07 2026-06-16 EDT			5-day change	1st Jan Change
2,377.80 ^INR	+0.56%		+5.44%	+29.36%

05-14	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
05-14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
SUN PHARMACEUTICAL INDUSTRIES LTD.					34
OTSUKA HOLDINGS CO., LTD.					12
CIPLA LIMITED					37
ZYDUS LIFESCIENCES LIMITED					30
KRKA, D. D.					6
GEDEON RICHTER					7
ONO PHARMACEUTICAL CO., LTD.					12
GLENMARK PHARMACEUTICALS LIMITED					10
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.				-	-
AJANTA PHARMA LIMITED					14
ASPEN PHARMACARE HOLDINGS LIMITED					4
HANMI PHARM. CO., LTD.					15
SIMCERE PHARMACEUTICAL GROUP LIMITED					5
JAMJOOM PHARMACEUTICALS FACTORY COMPANY					3
ASTRA INDUSTRIAL GROUP COMPANY				-	1
HAW PAR CORPORATION LIMITED		-	-	-	1
SUNSHINE LAKE PHARMA CO., LTD.	-	-		-	-
Average					13
Weighted average by Cap.					20